Introduction
Cytokines and growth factors are regulatory molecules that play a major role in the development and regulation of the hematopoietic and immune systems.
1,2 They contribute to the proliferation, survival, differentiation and activation of progenitor and mature cells through their specific binding to single or multi-chain receptors at the cell surface. 3, 4 To date, all these receptors couple to a tyrosine kinase activity following ligand binding. This enzymatic capacity can be brought about by cytoplasmic kinases of the JAK or SRC families that associate with the non-enzymatic receptors of the hematopoietin receptor family. 5, 6 Alternatively, three hematopoietic growth factors, colony-stimulating factor (CSF)-1, KIT ligand (KL) and FLT3 ligand (FL) directly bind to transmembrane receptor tyrosine kinases (RTK) of the class III that also include the nonhematopoietic receptors for the platelet-derived growth factors. 4, 7 Class III RTKs are activated by ligand-dependent dimerization and subsequent transphosphorylation of tyrosine residues. The resulting phosphotyrosines unmask the enzymatic activity and/or serve as docking sites for SH2 domain-containing cytoplasmic molecules such as phospholipase C␥, p85 subunit of phosphatidylinositol 3′ (PI3) kinase or GRB2.
Inducible bindings of these molecules to the receptor are initializing events that propagate a downstream signal leading to both a functional event and a subsequent termination signal. 10 It is likely that tight regulation of positive and negative events depends on the kinetics of formation of dynamic molecular complexes built by the presence of association domains such as SH2/3, PTB/PH, WW or PDZ domains. [11] [12] [13] [14] Complex formation is either inducible, as examplified by the phosphotyrosine dependence of SH2 binding, or constitutive, such as the interactions involving SH3 domains. The complexity of these mechanisms is underlined by the fact that many proteins are multidomain and multifunctional.
The FLT3 RTK is important for the development of B cell progenitors and the integrity of pluripotent hematopoietic stem cells in vivo. 15 In vitro studies have shown that other hematopoietic lineages, such as the T and monocytic compartments are affected by its ligand, FL. [16] [17] [18] To date, the most interesting biologic effects of FL reside in its strong capacity to expand pro-B cells [19] [20] [21] [22] and long-term culture-initiating cells (LTC-IC) 18, 23, 24 when combined with other cytokines. Signaling and substrate specificity of the murine FLT3 receptor have been studied by two groups. 25, 26 For this purpose, they used CSF1 receptor/FLT3 chimeras ectopically overexpressed either in fibroblasts or in interleukin (IL)-3-dependent Ba/F3 cells. We have analyzed tyrosine-phosphorylated molecules detected following stimulation by FL of myelomonocytic, monocytic and early-B cell lines that express FLT3 at the cell surface. 27 We found that p115 CBL and p52 SHC are the predominant tyrosine-phosphorylated proteins in myeloid cells, and p52 SHC and an unknown p115 protein in B cells. We found that FL stimulation did not modify the preformed association of CBL with GRB2 but increased p85 binding to CBL and induced CBL association with CRKII.
Materials and methods

Cell cultures and transfections
LAZ221 cells were purchased from the German Collection of Micro-organisms and Cell Cultures (DSM, Braunschweig, Germany) and THP1 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). JEA2 and OCI/AML5 were kind gifts from C Schiff (Centre d'Immunologie de Marseille, France) and M Minden (Ontario Cancer Institute, Toronto, Canada) respectively. All cells were grown in RPMI 1640 supplemented with 10% heat-inactivated (30 min, 56°C) fetal calf serum (FCS). The culture medium of the growth factor-dependent OCI/AML5 was further supplemented with 10% culture supernatant from the bladder carcinoma cell line 5637.
Figure 1
Tyrosine phosphorylation of cellular proteins after stimulation of hematopoietic cells with FL. Cells which have been starved for 24 h (see Materials and methods) were stimulated for the indicated times with 100 U/ml of FL. Cells were subsequently lysed and total cellular extracts were resolved by SDS-PAGE, transfered to nylon membrane and immunoblotted with an anti-phosphotyrosine (PY) antibody. Control loading of each lane was made by stripping the membrane and immunoblotting with an anti-p85 PI3 kinase antibody. Molecular weight markers (kDa) are shown on the left. 
Antibodies
Anti-phosphotyrosine monoclonal antibody (mAb) (4G10), rabbit polyclonal anti-human SHC and anti-p85 subunit of rat PI3 kinase antibodies were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Rabbit polyclonal anti-CBL (C-15) and anti-CRKII (C-18) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-GRB2 and anti SHC mAb were purchased from Transduction Laboratories (Lexington, KY, USA). Anti-TYK2 mAb T10.2 was a kind gift of S Pellegrini (Institut Pasteur, Paris, France).
Figure 2
A 115 kDa tyrosine-phosphorylated band is depleted by anti-CBL antibodies in OCI/AML5 and THP1 cells but not in JEA2 and LAZ221 cells. Cells were stimulated for 5 min by 100 U/ml of FL and lysed. The experiment was performed in triplicates for each cell line: one sample was loaded on an 8% polyacrylamide gel without treatment (left lanes); the other two samples were subjected to one round of immunoprecipitation with the anti-CBL antibody (middle lanes) or with total rabbit immunoglobulins (right lanes), respectively. Total proteins were precipitated from the resulting supernatants and loaded on the same gel. After electrophoresis, the gel was transfered to a nylon membrane and successively immunoblotted with an anti-PY (upper panels), anti-CBL (middle panels) and anti-TYK2 as control (lower panels) antibody. (a) THP1 and OCI/AML5, (b) LAZ221 and JEA2.
Cell stimulation and lysis
For Western blot analysis of total cell lysate, 1.5 × 10 6 cells were starved for 24 h in RPMI 1640 supplemented with 1% heat inactivated FCS. Cells were then stimulated with 100 units (U) of E. coli produced murine FL (kindly provided by DNAX, Palo Alto, CA, USA) for various times. Cells were then washed twice in ice-cold phosphate-buffered saline (PBS) and lysed in 90 l of 20 mm Tris-HCl pH 8, 2 mm EDTA pH 8, 1% Nodinet P-40 (NP-40), 1 mm sodium orthovanadate, 6 g/ml antipain, 10 g/ml aprotinin, 10 g/ml leupeptin, 10 g/ml pepstatin, 1 mm phenylmethylsulfonyl fluoride. Lysates were cleared by centrifugation and 30 l was heated in SDS/2-mercaptoethanol-containing buffer and separated by electrophoresis on 8% polyacrylamide gels.
For immunoprecipitation experiments, usually 5 × 10 6 cells were starved, stimulated and washed as mentioned above. Cells were then lysed in 1 ml of lysis buffer.
Immunoprecipitations
Clarified cell lysates were incubated for 2-4 h at 4°C with specific antibodies and protein A-or protein G-coupled sepharose (Pharmacia, Uppsala, Sweden). Immune complexes were washed three times with lysis buffer with the exception that detergent concentration was decreased to 0.1%. Immune complexes were then heated in SDS/2-mercaptoethanol-containing loading buffer and separated by polyacrylamide gel electrophoresis (PAGE).
Western immunoblotting
Polyacrylamide gels were transfered to Immobilon membrane (Millipore, St-Quentin-Yvelines, France) and the membrane was probed with the indicated antibody, usually at a concentration of 1 g/ml in PBS, 0.1% Tween-20, except for the 4G10 antibody that was diluted in Tris-buffered saline, 0.1% Tween-20. Horseradish peroxidase-coupled anti-mouse or anti-rabbit immunoglobulin antibodies (Dako, Trappes, France) were used for detection. For successive probing of the same membrane with different antibodies, stripping was performed in 100 mm 2-mercaptoethanol, 2% SDS, 62.5 mm TrisHCl pH6.8 for 30 min at 50°C.
Immunodepletions
Cells (5 × 10 5 ) were starved for 24 h, stimulated for 5 min with FL and lysed in 500 l as described above. Five micrograms of anti-CBL or control rabbit immunoglobulins were added to the lysates in the presence of protein A-coupled sepharose and the mix was incubated for 2 h at 4°C. Immunoprecipitates were pelleted by centrifugation and discarded. Proteins in the supernatants were then recovered by adding 700 l of cold acetone followed by centrifugation at 13 000 r.p.m. for 30 min. Protein-containing pellets were resuspended in 25 l lysis buffer plus 25 l SDS/2-mercaptoethanol-containing buffer and separated by SDS/PAGE.
Results
FL induces tyrosine phosphorylation of cellular proteins in cell lines of myeloid and lymphoid origins
Tyrosine phosphorylations induced by FL were analyzed in four cell lines that express the endogenous FLT3 receptor. OCI/AML5 is a cytokine-dependent myelomonocytic cell line 28 derived from an M4 acute myeloid leukemia (AML) and THP1 cells derive from an M5 AML and display phenotypic characteristics of immature monocytes. 29 Notably, both cell lines remain functional, at least partly, in that they can differentiate into macrophage-like cells upon exposure to phorbol ester. 30, 31 LAZ221 and JEA2 cell lines were obtained from acute lymphoid leukemia (ALL) and were defined as pre-and pro-B cells upon precise examination of their surface expression status (C Schiff, personal communication).
The four cell types were stimulated for various times ranging from 15 s to 60 min. A rapid increase in the cellular content of phosphotyrosine-containing proteins was observed in all cell lines that peaked around 2-5 min and decreased thereafter to reach the basal level at 30-60 min.
Phosphorylation patterns looked similar in all cell lines ( The p115 phosphoprotein in OCI/AML5 and THP1 cells is CBL To associate the p115 phosphoprotein (pp115) with a known gene product, we tested various candidates of appropriate molecular mass for their capacity to be tyrosine phosphorylated in response to FL stimulation of THP1 cells. Among the TYK2, JAK2, p120 RAS GTPase activating protein and CBL molecules, only the latter was phosphorylated in activated cells (see below). CBL is the product of the cellular counterpart of the v-cbl oncogene which is the transforming sequence of the Cas NS-1 retrovirus. 32, 33 This retrovirus arose in the mouse by recombination between Cas-Br-M virus and Cbl sequences. The in vivo function of CBL remains largely unknown.
To estimate the relationship between the observed pp115 and CBL, we first did an immunodepletion (see Materials and methods) on total lysates of cells stimulated for 5 min by FL, using anti-CBL polyclonal rabbit antiserum or total nonimmune rabbit immunoglobulins as a control. The pretreated (immunodepleted) lysates were then separated on polyacrylamide gels along with an untreated lysate and analyzed by Western blotting.
As shown in Figure 2a , pp115 level was highly diminished after CBL removal in OCI/AML5 and THP1 cells. Control immunoprecipitation and equivalent TYK2 detection argues for the specificity of the effect observed. Surprisingly, the same experiment done on LAZ221 and JEA2 (Figure 2b ) cells did not lead to a significant attenuation of pp115 despite the fact that endogenous CBL proteins were efficiently removed.
This indicates that in late myeloid but not in early B cells stimulated by FL, CBL is the major tyrosine-phosphorylated protein. The identity of the B cell-specific pp115 is presently not known.
The phosphoprotein of estimated molecular weight (MW) 55 is p52 SHC We used the same approach as above to characterize pp55. Because the SHC proteins are tyrosine phosphorylated in response to activation of a CSF1R/FLT3 chimera 25, 26 and following stimulation by a number of cytokines and growth
Figure 3
The 55 kDa tyrosine-phosphorylated band corresponds to p52 SHC . Cells were stimulated for 5 min by 100 U/ml of FL and lysed. This experiment was performed in triplicates for each cell line: one sample was loaded on an 10% polyacrylamide gel without treatment ( lanes 1, 4 and 7) ; the other two samples were subjected to one round of immunoprecipitation with the anti-SHC antibody (lanes 2, 5 and 8) or with total rabbit immunoglobulins (lanes 3, 6 and 9), respectively. Total proteins were precipitated from the resulting supernatants and loaded on the same gel. After electrophoresis, the gel was transfered to a nylon membrane and successively immunoblotted with Analysis of CBL and SHC contents in anti-phosphotyrosine immunoprecipitates. Cells were left unstimulated or were stimulated for 5 min with FL 100 U/ml and lysed in 1% NP-40 containing buffer. Lysates were subjected to immunoprecipitation with the 4G10 antiphosphotyrosine antibody. Immunoprecipitates were separated by SDS-PAGE, transfered to nylon membrane and subsequently immunoblotted with anti-CBL (upper panel) and anti-SHC antibodies (lower panel). As controls, total cellular lysates (TCL) of 5 × 10 5 stimulated cells were run along with the immunoprecipitates.
factors, 34 we first depleted SHC proteins and subsequently analyzed total cellular tyrosine phosphorylations. As shown in the middle panels of Figure 3 , all cell lines expressed p46 and p52 SHC (data not shown for THP1). The upper panel shows a profound decrease after SHC immunodepletion of a doublet signal with both highly and faintly phosphorylated components with sizes similar to p52 and p46 SHC , respectively. Concommitantly, we did not observe any quantitative decrease of the CBL protein (lower panel).
We conclude that p46 and p52 SHC are substrates for FLT3 or an FL-activated kinase, and strongly contribute to the increase in phosphotyrosine content of FL-stimulated cells.
Analysis of the SHC and CBL contents in antiphosphotyrosine immunoprecipitates
To confirm that CBL and SHC are phosphorylated on tyrosine residues in response to FLT3 activation, anti-phosphotyrosine immunoprecipitates from the four cell lines were analyzed by SDS-containing polyacrylamide gel electrophoresis (SDS-PAGE), transferred to membrane and analyzed by immunoblotting using antibodies specific for CBL and SHC. Figure 4 shows that there was a clear increase in CBL phosphorylation in THP1, OCI/AML5 and JEA2, but not in LAZ221 (probably because of a low signal intensity in this particular experiment, see Figure 5) .
A consistent basal level of p52 SHC phosphorylation was found in all four non-stimulated cell lines, that was further increased after a 5 min exposure to FL. Despite the fact that p46 and p52 SHC proteins are expressed in all four cell lines, tyrosine-phosphorylated p46 was detected at a low level, if detected.
As deduced from the data in Figure 1 and Figure 3 Tyrosine phosphorylation of CBL and association with p85 subunit of PI3 kinase and GRB2 but not SHC
The phosphorylation of CBL was directly assessed following immunoprecipitation with an anti-CBL antibody. As seen in Figure 5 , an increase in the CBL phosphotyrosine content was observed in JEA2 and THP1 cells stimulated by FL. A number of cytoplasmic components of the signal transduction cascades are constitutively or inducibly associated with CBL. Among them, the p85 subunit of PI3 kinase forms an inducible complex, primarily dependent on the p85 SH2 domains and phosphotyrosine(s) of CBL. [35] [36] [37] [38] In contrast, the adaptor molecule GRB2 binds CBL constitutively in most cases, mainly through its N-terminal SH3 domain. 39, 40 Figure 5 shows an increase of p85 in anti-CBL immunoprecipitates in THP1 and, to a lesser extent, in JEA2 cells. In contrast, a constitutive and invariant GRB2/CBL complex was detected. Similar results were obtained with LAZ221 and OCI/AML5 cells (data not shown). Tyrosine-phosphorylated SHC has been shown to associate with CBL following cytokine or growth factor stimulation. 41, 42 In the present experiment, SHC proteins were not detected in anti-CBL immunoprecipitates despite the fact that a tyrosine-phosphorylated protein with a size similar to p52 SHC is easily detectable ( Figure 5 and data not shown).
CBL phosphorylation is rapid and transient
We analyzed more precisely the time-dependent phosphorylation of CBL in THP1 cells. As shown in Figure 6 , CBL phosphorylation was rapidly increased 15 s after FL exposure, reached a plateau at 5 min and then decreased to basal level at 30 min. The GRB2 contents in anti-CBL immunoprecipitates remained constant over the period studied (data not shown).
Figure 5
Analysis of CBL phosphorylation and associated proteins in unstimulated and FL-stimulated hematopoietic cell lines. Total cellular lysates from 5 × 10 5 JEA2 or 1.5 × 10 5 THP1 unstimulated or FL-stimulated cells (lanes labeled TCL) and anti-CBL immunoprecipitates from 15 × 10 6 JEA2 or 5 × 10 6 THP1 cells (lanes labeled IP) were obtained and loaded on an 8% polyacrylamide gel. After transfer, the membrane was successively immunoblotted with anti-PY, anti-CBL, anti-p85 and anti-GRB2 antibodies, as indicated. The tyrosinephosphorylated protein with a size similar to p52 SHC is indicated by an arrowhead.
The CRKII SH2/SH3-containing adaptor molecule binds specifically to tyrosine-phosphorylated CBL in FL-stimulated cells
The products of the CRK protooncogene, respectively CRKI and CRKII, 43 bind to tyrosine-phosphorylated CBL in BCR-ABL-transformed hematopoietic cells 43, 44 and after various stimuli such as the activation of the T cell 45 and EGF receptors. 42 We detected CBL in anti-CRKII immunoprecipitates of JEA2 and THP1 cells exposed to FL for 5 min (Figure 7) . Blotting of the membrane with anti-phosphotyrosine antibody suggest that CBL is the major, if not the only tyrosinephosphorylated protein in anti-CRKII immunoprecipitates. However, we could not detect CRKII in anti-CBL immunoprecipitates of THP1 cells stimulated by FL, possibly because of the low efficiency of commercial anti-CRKII in Western blot analysis.
Discussion
In the complex process of hematopoiesis, proliferation and lineage commitment of progenitor cells are regulated by common and distinct mechanisms. Soluble and membrane-bound growth factors that are ligands for class III RTK, namely the FMS, KIT and FLT3 receptors, are involved in the expansion of various progenitor and mature cell compartments. 4, 7, [46] [47] [48] KL and FL concommitantly regulate hematopoietic stems cells and have specific activities on erythroid progenitors 17 and early B cell progenitors, respectively. 19, 20 Their activity is a direct consequence of intramolecular phosphorylation of homodimeric receptors. 49 The phosphorylated residues are docking sites for cytoplasmic signal transduction regulators with either intrinsic enzymatic activities or adaptor interaction domains or both. 9 This results in tyrosine phosphorylation of cytoplasmic molecules that initiate diverent and/or convergent signaling cascades that ultimately regulate, among others, gene transcription and cytoskeleton organization. To analyze the substrate specificities of the FLT3 receptor in hematopoietic cells, we focused on the qualitative analysis of tyrosinephosphorylated products in leukemia-derived myeloid and lymphoid cell lines expressing the endogenous FLT3 receptor. Importantly, the cell lines used in this study correlate with human normal FLT3-expressing hematopoietic progenitors since functional expression of FLT3 is detected on CD34 +
CD19
+ pro-B cells and all along the myelomonocytic differentiation pathway, including monocytes. 50 In cells of the myeloid lineage, ie myelomonocytic OCI/AML5 and monocytic THP1 cells, CBL and SHC were the prominent tyrosine-phosphorylated cellular proteins (Figures 1  and 2 ). Patterns of cellular phosphorylation in lymphoid cells, ie JEA2 pro-B and LAZ221 pre-B cells, were similar to the one observed in myeloid cells (Figure 1 ), but qualitatively differ in that CBL poorly contribute to pp115 in these cells. However, CBL was indeed phosphorylated in JEA2 and LAZ221. This indicates that the cellular response to FLT3 activation can partially depend on the cell type studied. This could be related to different functions of FL in vivo, on cells of the monocytic and B lineages, respectively. In support of this view, FL is a proliferative factor for B cell progenitors, 19, 20 whereas it can maintain self-renewal capacities of the murine M1 monocytic cell line. 51 CBL has a complex structure that includes features of transcription factors and of signaling molecules. 33 It is phosphorylated on tyrosine residues in response to a broad range of external stimuli, including T, B and cytokine receptors activation. 52 The function of CBL remains unclear. In view of its similarities to the product of the C. elegans sli-1 gene, 53 CBL is a possible negative regulator of RTK signal transduction.
In our experimental system, CBL was constitutively associated with the GRB2 adaptor. The adaptor subunit of PI 3-kinase, p85, was weakly bound to CBL in non-activated cells, and this association was increased in FL-stimulated cells. The binding of p85 to CBL depends mostly on the p85 SH2 domains. 35, 36 Two putative p85 SH2 binding sites -Y 683 CEM and Y 731 EAM -are present in the CBL sequence. 33, 54 Interestingly, p85 binds murine FLT3 in transfected cells at a site in the carboxy terminus of the receptor that is not conserved in the human receptor. 26 CBL may act as a surrogate adaptor to couple human FLT3 to the PI3 kinase pathway. In EGFstimulated cells, activation of PI3 kinase activity can be induced through association with both CBL and ERBB3 EGF receptor homolog.
36
GRB2 binding to CBL possibly couples to a SHCdependent/RAS-independent signaling pathway. In the particular case of T cell receptor activation, GRB2/CBL and GRB2/SOS complexes are indeed distinct. 38 We did not detect SHC association with CBL ( Figure 5 ). Other authors have In THP1 cells, CBL is rapidly and transiently phosphorylated on tyrosine following stimulation by FL. THP1 cells were left unstimulated or were stimulated for the indicated times with FL 100 U/ml. Cells were lysed and lysates were subjected to immunoprecipitation with anti-CBL. Immunoprecipitates were separated by SDS-PAGE and blotted to nylon membrane. In parallel, total cellular lysates (TCL) of 5 × 10 reported a low binding of CBL to SHC in CSF-1-and EGFstimulated cells. 41, 42 Interestingly, KIT, a receptor closely related to FLT3, induces CBL phosphorylation on tyrosines without detectable SHC association. 55 However, we do not exclude that SHC associates with CBL, possibly via GRB2, since (1) a phosphoprotein with a size similar to p52 SHC coprecipitates with CBL in FL-activated cells and (2) SHC detection in our immunoblot experiments is not very sensitive (data not shown). Because SHC was tyrosine phosphorylated in all the FL-activated cells we examined, it is likely that some activated SHC proteins couple to the RAS pathway. However, it will be of interest to determine if SHC phosphorylation involves its tyrosine 317 and/or tyrosines 239-240. 56 Inducible binding of CRKII to CBL is likely to involve CRKII SH2 domain to tyrosine-phosphorylated CBL residues in the carboxy terminus of the molecule, Y 700 MTP and/or Y 771 DVP, that match the consensus CRK SH2 binding site. 54 CRKII is thought to act as an adaptor and binds the C3G GDP-GTP exchange factor that in turn regulates the RAP1 small GTPbinding protein of the RAS family. 57, 58 RAP1 interferes with the RAS signaling pathway 59 and may initiate its own pathway as well.
The rapid tyrosine phosphorylation of CBL induced by FL ( Figure 6 ) suggests that it is a substrate of FLT3 or an FLT3-associated tyrosine kinase. There is preliminary evidence that the murine FLT3 receptor could indirectly couple to the ABL kinase through binding of the SH2 domain of 3BP2 60, 61 to a phosphotyrosine inside the kinase insert domain (R Rottapel, personal communication). This may provide a way to phosphorylate CRK SH2-binding sites of CBL that obey the substrate preference for the ABL kinase. This would be in agreement with the emerging scheme that receptor autophosphorylation provides docking sites for cytoplasmic molecules such as PLC␥ or p85, and that RTK-associated cytoplasmic tyrosine kinases phosphorylate exogenous substrates, 62 then initiating processive phosphorylation and subsequent cellular signalling. 63 In conclusion, this study has identified for the first time the prominent tyrosine-phosphorylated substrates involved in FLT3 signaling in hematopoietic cell lines and pointed out possible myeloid and lymphoid-restricted substrate specificities, respectively.
